Martin Illemann

1.7k total citations
39 papers, 1.2k citations indexed

About

Martin Illemann is a scholar working on Cancer Research, Oncology and Immunology and Allergy. According to data from OpenAlex, Martin Illemann has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 21 papers in Oncology and 10 papers in Immunology and Allergy. Recurrent topics in Martin Illemann's work include Protease and Inhibitor Mechanisms (20 papers), Peptidase Inhibition and Analysis (13 papers) and Cell Adhesion Molecules Research (10 papers). Martin Illemann is often cited by papers focused on Protease and Inhibitor Mechanisms (20 papers), Peptidase Inhibition and Analysis (13 papers) and Cell Adhesion Molecules Research (10 papers). Martin Illemann collaborates with scholars based in Denmark, Norway and Costa Rica. Martin Illemann's co-authors include Gunilla Høyer‐Hansen, Ole Didrik Lærum, Boye Schnack Nielsen, Ib Jarle Christensen, Leif R. Lund, Keld Danø, Nigel C. Bird, Ali W. Majeed, Rikke Løvendahl Eefsen and Gert G. Van den Eynden and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Martin Illemann

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Illemann Denmark 19 608 478 373 277 162 39 1.2k
Zofia von Marschall Germany 20 609 1.0× 398 0.8× 848 2.3× 243 0.9× 103 0.6× 26 1.6k
Kabir A. Khan United Kingdom 15 489 0.8× 217 0.5× 547 1.5× 320 1.2× 199 1.2× 21 1.2k
Shuji Kitahara Japan 14 707 1.2× 284 0.6× 425 1.1× 472 1.7× 229 1.4× 32 1.4k
Y Oshika Japan 23 745 1.2× 436 0.9× 996 2.7× 226 0.8× 319 2.0× 50 1.7k
Lidia Moserle Italy 18 496 0.8× 341 0.7× 647 1.7× 173 0.6× 111 0.7× 26 1.1k
Carla Mouta Carreira United States 10 951 1.6× 290 0.6× 994 2.7× 145 0.5× 153 0.9× 10 1.7k
Akimitsu Hiraki Japan 20 558 0.9× 366 0.8× 526 1.4× 218 0.8× 91 0.6× 47 1.3k
Yanli Su United States 15 472 0.8× 303 0.6× 790 2.1× 93 0.3× 198 1.2× 22 1.4k
Shinobu Iwai Japan 3 504 0.8× 356 0.7× 745 2.0× 277 1.0× 126 0.8× 6 1.3k
Carlo Hojilla Canada 12 811 1.3× 504 1.1× 732 2.0× 119 0.4× 148 0.9× 19 1.5k

Countries citing papers authored by Martin Illemann

Since Specialization
Citations

This map shows the geographic impact of Martin Illemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Illemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Illemann more than expected).

Fields of papers citing papers by Martin Illemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Illemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Illemann. The network helps show where Martin Illemann may publish in the future.

Co-authorship network of co-authors of Martin Illemann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Illemann. A scholar is included among the top collaborators of Martin Illemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Illemann. Martin Illemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eefsen, Rikke Løvendahl, Martin Illemann, Alexia Lopresti, et al.. (2023). ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy. Cancer Gene Therapy. 30(10). 1369–1381. 5 indexed citations
2.
Brungs, Daniel, Martin Illemann, Nicholas Hirst, et al.. (2019). Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma. Pathology. 51(5). 474–480. 10 indexed citations
3.
Christensen, Ib Jarle, Ben Vainer, Lars Bo Svendsen, et al.. (2015). The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study. Clinical Cancer Research. 22(10). 2427–2434. 16 indexed citations
4.
Ham, Boram, Ni Wang, María Celia Fernández, et al.. (2015). TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases. Cancer Research. 75(24). 5235–5247. 82 indexed citations
5.
Illemann, Martin, Gunilla Høyer‐Hansen, Ib Jarle Christensen, et al.. (2015). Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 33(4). 165.e15–165.e24. 25 indexed citations
6.
Eefsen, Rikke Løvendahl, Lars H. Engelholm, Warner Alpízar‐Alpízar, et al.. (2015). Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy. Cancer Microenvironment. 8(2). 93–100. 16 indexed citations
7.
Illemann, Martin, Rikke Løvendahl Eefsen, Nigel C. Bird, et al.. (2015). Tissue inhibitor of matrix metalloproteinase‐1 expression in colorectal cancer liver metastases is associated with vascular structures. Molecular Carcinogenesis. 55(2). 193–208. 20 indexed citations
8.
Eefsen, Rikke Løvendahl, Peter Vermeulen, Ib Jarle Christensen, et al.. (2015). Growth pattern of colorectal liver metastasis as a marker of recurrence risk. Clinical & Experimental Metastasis. 32(4). 369–381. 66 indexed citations
9.
Eynden, Gert G. Van den, Ali W. Majeed, Martin Illemann, et al.. (2013). The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications. Cancer Research. 73(7). 2031–2043. 171 indexed citations
10.
Lecomte, Julie, Silvia Blacher, André Gothot, et al.. (2012). Bone Marrow-derived Myofibroblasts Are the Providers of Pro-invasive Matrix Metalloproteinase 13 in Primary Tumor. Neoplasia. 14(10). 943–951. 28 indexed citations
11.
Costea, Daniela Elena, et al.. (2012). Time-dependent biological differences in molecular markers of high-grade urothelial cancer over 7 decades (ras proteins, pTEN, uPAR, PAI-1 and MMP-9). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(5). 541–551. 6 indexed citations
12.
Lund, Ida Katrine, Boye Schnack Nielsen, Kasper Almholt, et al.. (2011). Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. Developmental Biology. 358(1). 56–67. 17 indexed citations
13.
Santoni‐Rugiu, Eric, et al.. (2011). Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma. International Journal of Cancer. 130(11). 2734–2739. 17 indexed citations
14.
Rasch, Morten G., Ida Katrine Lund, Martin Illemann, Gunilla Høyer‐Hansen, & Henrik Gårdsvoll. (2010). Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cells. Protein Expression and Purification. 72(1). 87–94. 13 indexed citations
15.
Alpízar‐Alpízar, Warner, Ole Didrik Lærum, Martin Illemann, et al.. (2009). Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(3). 225–233. 38 indexed citations
16.
Illemann, Martin, Nigel C. Bird, Ali W. Majeed, et al.. (2008). Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor‐1 in colon cancer liver metastases. International Journal of Cancer. 124(8). 1860–1870. 70 indexed citations
17.
Lærum, Ole Didrik, et al.. (2007). Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. International Journal of Cancer. 122(4). 734–741. 34 indexed citations
18.
Nielsen, Boye Schnack, Fritz Rank, Martin Illemann, Leif R. Lund, & Keld Danø. (2007). Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor. International Journal of Cancer. 120(10). 2086–2095. 79 indexed citations
19.
Illemann, Martin, Ulla Hansen, Hans Jørgen Nielsen, et al.. (2004). Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1. American Journal of Clinical Pathology. 122(2). 256–265. 5 indexed citations
20.
Holten-Andersen, Mads, Ulla Hansen, Nils Brünner, et al.. (2004). Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinoma. International Journal of Cancer. 113(2). 198–206. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zofia von Marschall Breakdown of academic impact, for papers by Kabir A. Khan Breakdown of academic impact, for papers by Shuji Kitahara Breakdown of academic impact, for papers by Y Oshika Breakdown of academic impact, for papers by Lidia Moserle Breakdown of academic impact, for papers by Carla Mouta Carreira Breakdown of academic impact, for papers by Akimitsu Hiraki Breakdown of academic impact, for papers by Yanli Su Breakdown of academic impact, for papers by Shinobu Iwai Breakdown of academic impact, for papers by Carlo Hojilla
Rankless by CCL
2026